Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Non-cash Items: 2020-2023

Historic Non-cash Items for Mirum Pharmaceuticals (MIRM) over the last 4 years, with Dec 2023 value amounting to $131.8 million.

  • Mirum Pharmaceuticals' Non-cash Items rose 155.17% to $131.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $131.8 million, marking a year-over-year increase of 155.17%. This contributed to the annual value of $131.8 million for FY2023, which is 155.17% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Non-cash Items stood at $131.8 million for FY2023, which was up 155.17% from $51.6 million recorded in FY2022.
  • In the past 5 years, Mirum Pharmaceuticals' Non-cash Items ranged from a high of $131.8 million in FY2023 and a low of $32.6 million during FY2021.
  • Its 3-year average for Non-cash Items is $72.0 million, with a median of $51.6 million in 2022.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Non-cash Items declined by 19.67% in 2021 and then spiked by 155.17% in 2023.
  • Mirum Pharmaceuticals' Non-cash Items (Yearly) stood at $40.6 million in 2020, then fell by 19.67% to $32.6 million in 2021, then surged by 58.24% to $51.6 million in 2022, then skyrocketed by 155.17% to $131.8 million in 2023.